Page last updated: 2024-08-23

lovastatin and Epithelial Ovarian Cancer

lovastatin has been researched along with Epithelial Ovarian Cancer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, S; Gou, WF; Niu, ZF; Xiao, LJ; Zhao, Y; Zheng, HC1

Other Studies

1 other study(ies) available for lovastatin and Epithelial Ovarian Cancer

ArticleYear
The role of RhoC in ovarian epithelial carcinoma: a marker for carcinogenesis, progression, prognosis, and target therapy.
    Gynecologic oncology, 2013, Volume: 130, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Biomarkers, Tumor; Carcinoma, Ovarian Epithelial; Caspase 3; Cell Differentiation; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; G1 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inhibitor of Apoptosis Proteins; Lovastatin; Matrix Metalloproteinase 9; Middle Aged; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Ovary; Phosphorylation; Proto-Oncogene Proteins c-akt; rho GTP-Binding Proteins; rhoC GTP-Binding Protein; Ribosomal Protein S6 Kinases, 70-kDa; RNA, Messenger; STAT3 Transcription Factor; Survivin; Tissue Array Analysis; Transfection; Vascular Endothelial Growth Factor A; Young Adult

2013